| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NOVARTIS A G | 478,921 | 45,179,000 | 5.58% | ||
| 2 | SPDR S&P BIOTECH ETF | 200,000 | 39,404,000 | 4.87% | Put | |
| 3 | PFIZER INC | 1,274,013 | 37,673,000 | 4.65% | ||
| 4 | TEVA PHARMACEUTICAL INDS LTD | 647,438 | 34,845,000 | 4.30% | ||
| 5 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 485,500 | 31,028,000 | 3.83% | Put | |
| 6 | ALLERGAN PLC | 122,100 | 29,460,000 | 3.64% | ||
| 7 | MERCK & CO INC | 417,530 | 24,751,000 | 3.06% | ||
| 8 | ABBVIE INC | 403,550 | 23,309,000 | 2.88% | ||
| 9 | Allergan Inc | 128,840 | 22,958,000 | 2.84% | ||
| 10 | SHIRE PLC | 259,085 | 22,429,000 | 2.77% | ||
| 11 | ISRAMCO INC | 103,111,944 | 22,136,000 | 2.73% | ||
| 12 | JOHNSON & JOHNSON | 207,406 | 22,107,000 | 2.73% | ||
| 13 | GILEAD SCIENCES INC | 194,200 | 20,673,000 | 2.55% | Call | |
| 14 | TEVA PHARMACEUTICAL INDUSTRIES LTD | 375,200 | 20,167,000 | 2.49% | Call | |
| 15 | VERTEX PHARMACEUT | 150,000 | 16,847,000 | 2.08% | ||
| 16 | GLAXOSMITHKLINE PLC | 291,300 | 13,391,000 | 1.65% | Call | |
| 17 | VALEANT PHARMACEUTICALS INTL | 98,550 | 12,930,000 | 1.60% | ||
| 18 | VALEANT PHARMACEUTICALS INTL | 97,200 | 12,753,000 | 1.58% | Call | |
| 19 | MALLINCKRODT PUB LTD CO SHS | 135,940 | 12,255,000 | 1.51% | ||
| 20 | UNITED THERAPEUTICS | 88,840 | 11,429,000 | 1.41% | ||
| 21 | ISRAEL CHEMICALS LTD SHS | 1,380,000 | 9,977,000 | 1.23% | ||
| 22 | ELBIT SYS LTD | 144,759 | 8,974,000 | 1.11% | ||
| 23 | ORBOTECH LTD | 571,532 | 8,901,000 | 1.10% | ||
| 24 | BIOMARIN | 121,970 | 8,801,000 | 1.09% | ||
| 25 | Astrazeneca Plc ADR F | 120,000 | 8,573,000 | 1.06% | ||
| 26 | VERINT SYS INC COM | 151,468 | 8,423,000 | 1.04% | ||
| 27 | SANOFI CONTGNT VAL RT | 67,960 | 7,689,000 | 0.95% | ||
| 28 | SALIX PHARMACEUTICALS INC | 48,500 | 7,578,000 | 0.94% | Call | |
| 29 | PUMA BIOTECHNOLOGY | 30,296 | 7,228,000 | 0.89% | ||
| 30 | ASTRAZENECA PLC | 97,100 | 6,937,000 | 0.86% | Call | |
| 31 | AMGEN INC | 48,550 | 6,819,000 | 0.84% | ||
| 32 | ACORDA THERAPEUTICS | 199,105 | 6,746,000 | 0.83% | ||
| 33 | LILLY ELI & CO | 97,100 | 6,297,000 | 0.78% | ||
| 34 | MEDIVATION INC | 63,115 | 6,240,000 | 0.77% | ||
| 35 | B COMMUNICATIONS LTD | 321,431 | 6,175,000 | 0.76% | ||
| 36 | Medassets Inc | 433,889 | 6,103,000 | 0.75% | ||
| 37 | SEATTLE GENETICS INC | 155,360 | 5,776,000 | 0.71% | ||
| 38 | DYAX CORP COM CVR | 517,556 | 5,238,000 | 0.65% | ||
| 39 | APPLE COMPUTER INC | 50,045 | 5,042,000 | 0.62% | ||
| 40 | ITURAN LOCATION AND CONTROL LTD | 231,115 | 4,861,000 | 0.60% | ||
| 41 | AMAG PHARMACEUTICALS INC COM | 150,230 | 4,794,000 | 0.59% | ||
| 42 | CLOVIS ONCOLOGY INC | 101,955 | 4,625,000 | 0.57% | ||
| 43 | PHARMACYCLICS INC | 38,840 | 4,561,000 | 0.56% | ||
| 44 | CSX CORP | 139,675 | 4,478,000 | 0.55% | ||
| 45 | GLAXOSMITHKLINE PLC | 97,100 | 4,464,000 | 0.55% | ||
| 46 | Mylan Inc | 97,100 | 4,417,000 | 0.55% | ||
| 47 | AUSPEX PHARMACEUTICALS INC | 165,074 | 4,237,000 | 0.52% | ||
| 48 | BROADCOM CORP CL A | 99,360 | 4,016,000 | 0.50% | ||
| 49 | APPLIED GENETIC TECHNOL CORP | 210,724 | 3,922,000 | 0.48% | ||
| 50 | NPS Pharmaceuticals, Inc. | 139,420 | 3,625,000 | 0.45% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001178913-14-003634, filed 2014.11.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
